A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Clinical trial NCT01886820 · UNKNOWN
Trial details
- NCT number
- NCT01886820
- Sponsor
- Navidea Biopharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.